絞り込み

16645

広告

「denosumab」の検索結果

2898件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Favorable skeletal benefit/risk of long-term denosumab therapy: A virtual-twin analysis of fractures prevented relative to skeletal safety events observed.

Spectrum of histological features of Denosumab treated Giant Cell Tumor of Bone; potential pitfalls and diagnostic challenges for pathologists.

Real-world use of denosumab and bisphosphonates in patients with solid tumours and bone metastases in Germany.

[Giant cell tumor of bone : Morphology, molecular pathogenesis, and differential diagnosis].

A pragmatic, randomised, multicentre trial comparing 4-weekly vs. 12-weekly administration of bone-targeted agents (denosumab, zoledronate or pamidronate) in patients with bone metastases.

[Expression of H3.3 G34W mutant-specific antibody in giant cell tumors of bone and its diagnostic value].

Media coverage of drug regulatory agencies' safety advisories: a case study of citalopram and denosumab.

Immune system and bone microenvironment: rationale for targeted cancer therapies.

Use of denosumab to treat refractory hypercalcemia in a peritoneal dialysis patient with immobilization and tertiary hyperparathyroidism.

Cost-effectiveness of denosumab for high-risk postmenopausal women with osteoporosis in Thailand.

Recurrent giant cell tumour of the thoracic spine managed by total en bloc spondylectomy and denosumab therapy: a case report.

Overview of treatment approaches to osteoporosis.

Denosumab salvage therapy in a patient with a locally advanced and refractory sellar giant cell tumour of bone.

Denosumab in postmenopausal women with osteoporosis and diabetes: Subgroup analysis of FREEDOM and FREEDOM extension.

Denosumab for dialysis patients with osteoporosis: A cohort study.

Osteoporosis management in Australian general practice: an analysis of current osteoporosis treatment patterns and gaps in practice.

State of art and advances on the treatment of bone metastases from breast cancer: a concise review.

[A Case of atypical Femoral Fracture after Dosing Denosumab].

Risk of Cataract Surgery and Age-Related Macular Degeneration After Initiation of Denosumab vs Zoledronic Acid for Osteoporosis: A Multi-Database Cohort Study.

New agents for prostate cancer.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります